Carolina Molecular Teams Up with Pixelgen
Kit offers novel protein interactomics analysis of immune cells
In a groundbreaking development, Carolina Molecular Inc., a prominent molecular testing services laboratory, has formed a partnership with Pixelgen Technologies AB to enhance the accessibility of advanced protein interactomics capabilities for researchers and clinicians across the United States.
With this collaboration, Carolina Molecular is set to become the first certified service provider in the U.S. for Pixelgen's innovative Proximity Network Assay. This technology is crucial for gaining insights into protein-protein interactions and cellular functions by analyzing the proximity of proteins located on the cell surface. Such understanding is essential in the fields of immuno-oncology, cell therapy, hematology, and biomarker discovery, driving forward the quest for effective therapeutic solutions.
The Significance of Protein Interactomics
Pixelgen's unique technology introduces a significant omics dimension to the study of proteomics—by meticulously mapping the interactome of cell surface proteins at a single-cell level. Their proprietary Pixelgen Proxiome Kit enables nanoscale spatial analysis of immune cell proteins efficiently. The assay employs DNA-barcoded antibodies combined with rolling circle amplification to construct high-resolution maps of protein interactions, localizations, clustering, and abundance.
This technique provides fresh perspectives on disease mechanisms, response to pharmaceuticals, and the discovery of biomarkers. The workflow automates the generation of sequencer-ready libraries that can seamlessly integrate with standard next-generation sequencing (NGS) platforms, making the process accessible and efficient for researchers.
Expert Insight from Carolina Molecular
Trent Carrier, President of Carolina Molecular, highlighted the need for such technology, stating, "Partnering with Pixelgen is a direct response to the demands of our clients who seek to deepen their molecular insights through multiomic studies. Understanding interactions between proteins is vital for researchers in immuno-oncology and cell therapy. With our certification as the first U.S. service provider for this innovative technology, we can empower our partners to explore these critical interactions, thus accelerating their therapeutic programs."
Leveraging its advanced NGS Foundry, Carolina Molecular is well-equipped to provide detailed and high-quality biometric data utilizing the Pixelgen platform. This collaboration directly addresses the increasing need for reliable, domestically focused service providers capable of managing sensitive samples, especially in complex multiomic research endeavors.
Building a Strong Network for Scientific Progress
Simon Fredriksson, co-founder and CEO of Pixelgen, expressed enthusiasm about the partnership: "Establishing a robust network of service providers is crucial for making protein interactomics accessible to a broader audience within the scientific community. We are excited to collaborate with Carolina Molecular, known for its operational proficiency and scientific credibility. Their deep expertise in sequencing and bioinformatics positions them as the ideal partner in generating quality protein interactomics data, which can significantly aid research in vital areas like cell therapy and immuno-oncology."
About Carolina Molecular
Carolina Molecular is recognized as a leading molecular testing laboratory with a strong legacy that spans over 25 years. They offer comprehensive services, including CAP/CLIA-certified and NYS registered testing for contract research organizations and clinical trial sponsors. In addition to project-based sequencing through their NGS Foundry, they also provide Quality Control testing catering to biomanufacturing, food safety, and environmental monitoring needs.
What distinguishes Carolina Molecular is their commitment to customer service, ensuring prompt responses and straightforward pricing without hidden hassles. They support a variety of molecular testing projects, assuring all clients, regardless of scale, the highest quality outcomes. Their experienced operations and bioinformatics teams serve as an extension of their clients' research efforts, offering top-notch analysis and reporting capabilities.
About Pixelgen Technologies AB
Pixelgen is dedicated to advancing biology through high-resolution tools that clarify the molecular foundations of cellular functionality. Their patented Proximity Network Assay provides unprecedented nanoscale spatial analysis of immune cell proteins and supports the Pixelgen Proxiome Kit, which is vital for precision medicine. This core technology is designed to fuel a growing array of products aimed at innovative research within immunology, hematology, and cell therapies. Founded in 2020, Pixelgen is backed by passionate innovators and venture funding.
Frequently Asked Questions
What does the partnership between Carolina Molecular and Pixelgen involve?
The partnership enhances access to advanced protein interactomics analysis technologies, specifically through the Pixelgen Proxiome Kit.
Why is protein interactomics important in scientific research?
It provides insights into protein-protein interactions and cellular responses, which are crucial for advancing treatments in fields like immuno-oncology and cell therapy.
How does the Proximity Network Assay work?
This assay uses DNA-barcoded antibodies to map protein interactions on cell surfaces, offering detailed insights into protein behavior and functions.
What makes Carolina Molecular unique?
The company stands out due to its fast response times, clear pricing, and a commitment to high-quality standards in molecular testing.
What is Pixelgen's mission?
Pixelgen aims to deliver biology at the highest possible resolution, focusing on understanding cellular functions through innovative technologies.
